Literature DB >> 1705642

Point mutation in meningococcal por A gene associated with increased endemic disease.

B T McGuinness1, I N Clarke, P R Lambden, A K Barlow, J T Poolman, D M Jones, J E Heckels.   

Abstract

The por A gene, which encodes expression of meningococcal class 1 outer membrane protein, responsible for antigenic subtype specificity, has been cloned and sequenced in an isolate of Neisseria meningitidis (B:15:P1.7,16) from a patient in the Gloucester area with meningococcal meningitis. Comparison of the sequence with that of the equivalent gene from the P1.7,16 reference strain reveals a point mutation which generates a single aminoacid change in the epitope responsible for P1.16 specificity. Monoclonal antibodies with P1.16 specificity do not react with synthetic peptides that correspond to the altered epitope, and do not promote complement-mediated bactericidal killing of the isolate. Analysis of other strains shows widespread distribution of infections due to B:15:P1.7,16 meningococci with the altered epitope (P1.16b) in England and Wales.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705642     DOI: 10.1016/0140-6736(91)91297-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  90 in total

1.  Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread.

Authors:  J Jelfs; R Munro; E Wedege; D A Caugant
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

2.  Multiple mechanisms of phase variation of PorA in Neisseria meningitidis.

Authors:  A van der Ende; C T Hopman; J Dankert
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci.

Authors:  K A Jolley; L Appleby; J C Wright; M Christodoulides; J E Heckels
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Phosphorylation of the lipid A region of meningococcal lipopolysaccharide: identification of a family of transferases that add phosphoethanolamine to lipopolysaccharide.

Authors:  Andrew D Cox; J Claire Wright; Jianjun Li; Derek W Hood; E Richard Moxon; James C Richards
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

5.  An in vitro strategy for the selective isolation of anomalous DNA from prokaryotic genomes.

Authors:  M W J van Passel; A Bart; R J A Waaijer; A C M Luyf; A H C van Kampen; A van der Ende
Journal:  Nucleic Acids Res       Date:  2004-08-10       Impact factor: 16.971

6.  Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.

Authors:  E R van der Voort; P van der Ley; J van der Biezen; S George; O Tunnela; H van Dijken; B Kuipers; J Poolman
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

7.  Disease and Carrier Isolates of Neisseria meningitidis Cause G1 Cell Cycle Arrest in Human Epithelial Cells.

Authors:  Michael von Papen; Wilhelm F Oosthuysen; Jérôme Becam; Heike Claus; Alexandra Schubert-Unkmeir
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

8.  Entry of Neisseria meningitidis into mammalian cells requires the Src family protein tyrosine kinases.

Authors:  Heiko Slanina; Alexandra König; Sabrina Hebling; Christof R Hauck; Matthias Frosch; Alexandra Schubert-Unkmeir
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

9.  Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate.

Authors:  Peter T Beernink; Arunas Leipus; Dan M Granoff
Journal:  Clin Vaccine Immunol       Date:  2006-07

10.  The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.

Authors:  Guillermo Madico; Jo Anne Welsch; Lisa A Lewis; Anne McNaughton; David H Perlman; Catherine E Costello; Jutamas Ngampasutadol; Ulrich Vogel; Dan M Granoff; Sanjay Ram
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.